MacroGenics
MGNX
#8687
Rank
C$0.27 B
Marketcap
C$4.25
Share price
1.62%
Change (1 day)
83.15%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): C-$0.12

According to MacroGenics's latest financial reports the company's current EPS (TTM) is C-$0.06794. In 2024 the company made an earnings per share (EPS) of C-$1.45 a decrease over its 2023 EPS that were of C-$0.20.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.12-91.92%
2024C-$1.45613.33%
2023C-$0.20-92.31%
2022C-$2.65-42.14%
2021C-$4.5836.44%
2020C-$3.36-21.84%
2019C-$4.29-24.58%
2018C-$5.69675.93%
2017C-$0.73-68.05%
2016C-$2.30168.25%
2015C-$0.86-55%
2014C-$1.903400%
2013C-$0.05435-108.68%
2012C$0.6324.49%
2011C$0.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.85-2,820.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.29-46,148.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$19.47-28,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$9.31-13,800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$9.93-14,720.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.70-7,020.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C-$2.41 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA